Zylox-Tonbridge (ZYLOXTB) Sets Final Dividend at RMB 0.22 per Share for FY 2025

Bulletin Express

04/21

Zylox-Tonbridge Medical Technology Co., Ltd. has declared a final ordinary cash dividend of RMB 0.22 per share for the financial year ended 31 December 2025. The payout is subject to shareholder approval at the annual general meeting scheduled for 13 May 2026.

Key timetable • Ex-dividend date: 27 May 2026 • Last day to lodge share transfers: 28 May 2026 (16:30) • Book-closure period: 29 May – 02 June 2026 • Record date: 02 June 2026 • Payment date: 18 June 2026

The dividend will be distributed in Hong Kong dollars; the applicable exchange rate and any withholding tax details will be announced separately. Tricor Investor Services Limited will act as the share registrar at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.

The company’s board currently comprises three executive directors (Dr. Jonathon Zhong Zhao, Mr. Yang Xie, Dr. Zheng Li), two non-executive directors (Dr. Steven Dasong Wang, Mr. Dongfang Li), and three independent non-executive directors (Dr. Jian Ji, Ms. Yun Qiu, Dr. Xiang Qian).

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1100028333"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1100028333\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1100028333?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-21 17:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100028333","market":"us","top_or_hot":-1,"title":"Zylox-Tonbridge (ZYLOXTB) Sets Final Dividend at RMB 0.22 per Share for FY 2025","media":"Bulletin Express","content":"<p>Zylox-Tonbridge Medical Technology Co., Ltd. has declared a final ordinary cash dividend of RMB 0.22 per share for the financial year ended 31 December 2025. The payout is subject to shareholder approval at the annual general meeting scheduled for 13 May 2026.</p>\n<p>Key timetable  \n• Ex-dividend date: 27 May 2026  \n• Last day to lodge share transfers: 28 May 2026 (16:30)  \n• Book-closure period: 29 May – 02 June 2026  \n• Record date: 02 June 2026  \n• Payment date: 18 June 2026</p>\n<p>The dividend will be distributed in Hong Kong dollars; the applicable exchange rate and any withholding tax details will be announced separately. Tricor Investor Services Limited will act as the share registrar at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.</p>\n<p>The company’s board currently comprises three executive directors (Dr. Jonathon Zhong Zhao, Mr. Yang Xie, Dr. Zheng Li), two non-executive directors (Dr. Steven Dasong Wang, Mr. Dongfang Li), and three independent non-executive directors (Dr. Jian Ji, Ms. Yun Qiu, Dr. Xiang Qian).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zylox-Tonbridge (ZYLOXTB) Sets Final Dividend at RMB 0.22 per Share for FY 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZylox-Tonbridge (ZYLOXTB) Sets Final Dividend at RMB 0.22 per Share for FY 2025\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-04-21 17:44</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Zylox-Tonbridge Medical Technology Co., Ltd. has declared a final ordinary cash dividend of RMB 0.22 per share for the financial year ended 31 December 2025. The payout is subject to shareholder approval at the annual general meeting scheduled for 13 May 2026.</p>\n<p>Key timetable  \n• Ex-dividend date: 27 May 2026  \n• Last day to lodge share transfers: 28 May 2026 (16:30)  \n• Book-closure period: 29 May – 02 June 2026  \n• Record date: 02 June 2026  \n• Payment date: 18 June 2026</p>\n<p>The dividend will be distributed in Hong Kong dollars; the applicable exchange rate and any withholding tax details will be announced separately. Tricor Investor Services Limited will act as the share registrar at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.</p>\n<p>The company’s board currently comprises three executive directors (Dr. Jonathon Zhong Zhao, Mr. Yang Xie, Dr. Zheng Li), two non-executive directors (Dr. Steven Dasong Wang, Mr. Dongfang Li), and three independent non-executive directors (Dr. Jian Ji, Ms. Yun Qiu, Dr. Xiang Qian).</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02190","symbol_name":"歸創通橋","start_time":0,"source_url":"","article_id":"1100028333","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100028333","pubTimestamp":1776764648,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zylox-Tonbridge Medical Technology Co., Ltd. has declared a final ordinary cash dividend of RMB 0.22 per share for the financial year ended 31 December 2025. The payout is subject to shareholder...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02190":"归创通桥"},"translate_title":"Zylox-Tonbridge(ZYLOXTB)将2025财年末期股息定为每股人民币0.22元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":1},"content_text":"Zylox-Tonbridge Medical Technology Co., Ltd. has declared a final ordinary cash dividend of RMB 0.22 per share for the financial year ended 31 December 2025. The payout is subject to shareholder approval at the annual general meeting scheduled for 13 May 2026.\nKey timetable  \n• Ex-dividend date: 27 May 2026  \n• Last day to lodge share transfers: 28 May 2026 (16:30)  \n• Book-closure period: 29 May – 02 June 2026  \n• Record date: 02 June 2026  \n• Payment date: 18 June 2026\nThe dividend will be distributed in Hong Kong dollars; the applicable exchange rate and any withholding tax details will be announced separately. Tricor Investor Services Limited will act as the share registrar at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.\nThe company’s board currently comprises three executive directors (Dr. Jonathon Zhong Zhao, Mr. Yang Xie, Dr. Zheng Li), two non-executive directors (Dr. Steven Dasong Wang, Mr. Dongfang Li), and three independent non-executive directors (Dr. Jian Ji, Ms. Yun Qiu, Dr. Xiang Qian).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}